严重脑损伤路径对结局、资源与器官捐献的影响:区域神经科学ICU的3年经验
在英格兰西南部一家区域神经科学ICU,2015至2018年共收入85例严重脑损伤(DBI)患者,占全部入院的1.3%。与非DBI患者相比,DBI患者中位ICU停留时间更短(1.14天 vs 2.93天,p<0.001),撤除生命支持治疗的决策更早(中位26.2小时 vs 84.8小时,p<0.001)。超过8%的DBI患者存活,31%进展为脑死亡(一般人群为7.1%,p<0.001),25%成为实体器官捐献者(一般人群为1.3%,p<0.001)。引入DBI路径后3年内,脑死亡后捐献(DBD)与循环死亡后捐献(DCD)的比例增加(p=0.024)。作者结论认为,收入ICU并避免早期撤除生命支持可识别意外存活者,DBI路径增加器官捐献潜力,获益大于对ICU资源的少量影响。
要点
- 疑似DBI患者收入ICU并避免早期撤除生命支持,超过8%的DBI患者存活,31%进展为脑死亡。
- DBI患者中位ICU停留时间1.14天 vs 非DBI患者2.93天(p<0.001),撤除生命支持决策中位26.2小时 vs 84.8小时(p<0.001)。
- DBI患者25%成为实体器官捐献者,一般人群为1.3%(p<0.001)。
- 引入DBI路径后3年内,DBD与DCD捐献比例增加(p=0.024)。
- 预后评分系统不能为该人群提供准确的生存率估计。
适用人群与场景
- 2015至2018年收入英格兰西南部一家区域神经科学ICU的严重脑损伤(DBI)患者,占全部ICU入院的1.3%。
处置流程与药物剂量
- 将疑似DBI患者收入ICU并避免早期撤除生命支持治疗,以识别意外存活者并为家属在生命终末期决策提供更多时间(作者结论)。
研究设计与关键结果
- 研究类型为在区域神经科学ICU开展的3年经验比较分析,DBI患者85例(占全部入院的1.3%),并与非DBI患者比较结局。
- DBI患者中位ICU停留时间显著短于非DBI患者,1.14天 vs 2.93天(p<0.001)。
- DBI患者撤除生命支持治疗的决策显著更早,中位26.2小时 vs 84.8小时(p<0.001)。
- 超过8%的DBI患者存活,31%进展为脑死亡,一般人群为7.1%(p<0.001)。
- 25%的DBI患者成为实体器官捐献者,一般人群为1.3%(p<0.001)。
- 引入DBI路径后3年内,脑死亡后捐献(DBD)与循环死亡后捐献(DCD)的比例增加(p=0.024)。
- 预后评分系统不能为该人群提供准确的生存率估计。
证据类型、等级与局限
- 证据类型:单家区域神经科学ICU的3年经验比较分析(摘要未报告证据等级)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,将疑似DBI患者收入ICU并避免早期撤除生命支持,可识别意外存活者并为家属在生命终末期决策提供更多时间。
- 作者认为,DBI路径增加器官捐献潜力并增加DBD捐献者比例,这些获益大于DBI路径对ICU资源的少量影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 1 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the impact of introducing a devastating brain injury (DBI) pathway on patient outcome, intensive care unit (ICU) resources, and organ donation practice in the first 3 years of implementation in a regional neurosciences ICU in the South West of England.
METHODS: Patients with DBI admitted to our ICU between 2015 and 2018 were identified from our ICU database and their outcomes compared to those of non-DBI patients. Data were also obtained from the national potential donor audit to compare organ donation metrics before and after the introduction of the DBI pathway. Organ donation metrics in DBI patients and non-DBI patients were compared once the pathway had been implemented.
RESULTS: We admitted 85 DBI patients (1.3% of all admissions), with a significantly shorter median length of ICU stay than in non-DBI patients, 1.14 versus 2.93 days (p < 0.001). Decisions for withdraw life-sustaining treatments (WLST) were made significantly earlier in DBI patients, median 26.2 versus 84.8 h (p < 0.001). Over 8% of DBI patients survived, while 31% progressed to brain death compared to 7.1% in the general population (p < 0.001), and 25% become solid organ donors compared to 1.3% of the general population (p < 0.001). There was an increase in the proportion of donors after brain death (DBD) to donors after circulatory death (DCD) in the 3 years following the introduction of the DBI pathway (p = 0.024). There was also an increased proportion of DBD donors to DCD donors of 76% versus 24% in the DBI group compared to 62% versus 38% (p = 0,002) in the non-DBI population. Prognostic scoring systems do not provide accurate estimates of survival rate in this population.
CONCLUSIONS: Admitting patients with perceived DBI to ICU and avoiding the early WLST allows identification of unexpected survivors and gives families more time in decision making at the end of life. The DBI pathway increases the potential for organ donation and increases the proportion of DBD donors. These benefits outweigh the small impact of a DBI pathway on ICU resources.
参考来源
- Rivers J, Manara AR, Thomas I, et al. Impact of a Devastating Brain Injury Pathway on Outcomes, Resources, and Organ Donation: 3 Years' Experience in a Regional Neurosciences ICU. Neurocrit Care. 2020. PMID: 31773544. doi:10.1007/s12028-019-00879-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。